Prosecution Insights
Last updated: August 17, 2026

Examiner: ABDULLAH, AAISHA

Tech Center 3700 • Art Units: 3681 3686 3792

This examiner grants 24% of resolved cases

Performance Statistics

24.5%
Allow Rate
-45.5% vs TC avg
70
Total Applications
+40.7%
Interview Lift
1431
Avg Prosecution Days
Based on 49 resolved cases, 2023–2026

Rejection Statute Breakdown

38.0%
§101 Eligibility
3.2%
§102 Novelty
43.3%
§103 Obviousness
10.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19305467 OPTIMIZATION AND PERSONALIZATION OF THERAPEUTIC PROTOCOLS Non-Final OA Roche Diabetes Care, Inc.
17488962 PREDICTION OF HEART FAILURE STATUS Non-Final OA Cardiac Pacemakers, Inc.
18144125 STRUCTURED MEDICAL DATA CLASSIFICATION SYSTEM FOR MONITORING AND REMEDIATING TREATMENT RISKS Final Rejection Carnegie Mellon University
16436893 DECENTRALIZED PRESCRIPTION REFILLS Non-Final OA International Business Machines Corporation
19028289 Forecasting Arterial Embolic And Bleeding Events Non-Final OA Cerner Innovation, Inc.
19028327 Forecasting Arterial Embolic And Bleeding Events Non-Final OA Cerner Innovation, Inc.
19028386 Forecasting Arterial Embolic And Bleeding Events Non-Final OA Cerner Innovation, Inc.
19028886 Forecasting Arterial Embolic And Bleeding Events Non-Final OA Cerner Innovation, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month